title: Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning.
abstract: Autologous technetium 99m-labeled phagocyte scanning has been used to assess disease activity in inflammatory bowel disease in 51 consecutive patients. Strong correlations were found between the 24-h fecal excretion of isotope and the histologic score of mucosal biopsy specimens (rS = 0.84, p less than 0.001, where rS is Spearman's rank correlation coefficient), and between the 24-h fecal excretion of isotope and a clinical inflammatory bowel disease activity index based on the Crohn's disease activity index (rS = 0.87, p less than 0.001). To develop a clinically useful and objective measure of inflammatory bowel disease activity that did not require a 24-h stool collection, the intensity of bowel uptake on scanning was graded visually from 0 to 4, a ratio of count rates for the region of interest to the iliac crest reference region was calculated, and the rapidity of labeled phagocyte uptake into inflamed bowel was measured as the peak uptake time. Visual grading of disease activity on the scans was validated by comparing it with the ratio of count rates from inflamed bowel regions of interest and those from the iliac crest reference region. The ratio of count rates showed a significant correlation with the clinical disease activity index (r = 0.75, p less than 0.001). The visual scan grade also correlated well with the clinical activity index (r = 0.87, p less than 0.001). Count rates from hourly scans were also used to calculate the time of peak uptake of counts for a given region of interest. There was a strong negative correlation between this peak uptake time and the fecal excretion of isotope (rS = -0.81, p less than 0.001), a clinical activity index (r = -0.60, p less than 0.001), and the histologic score of the mucosal biopsy specimens (r = -0.84, p less than 0.001). These results indicate that the technetium 99m-labeled phagocyte scan provides an objective assessment of disease activity in inflammatory bowel disease using the visual scan grade, ratio of count rates for the region of inflamed bowel, or by the peak uptake time, thereby avoiding the problems associated with fecal collections. This scanning test may prove to be of significant value in clinical management and in the assessment of treatment response.
authors.affiliation: Department of Medicine, Woden Valley Hospital, Garran, Australia.
authors.forename: W E
authors.initials: WE
authors.lastname: Pullman
authors.forename: P J
authors.initials: PJ
authors.lastname: Sullivan
authors.forename: P J
authors.initials: PJ
authors.lastname: Barratt
authors.forename: J
authors.initials: J
authors.lastname: Lising
authors.forename: J A
authors.initials: JA
authors.lastname: Booth
authors.forename: W F
authors.initials: WF
authors.lastname: Doe
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003093:Colitis, Ulcerative / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D003424:Crohn Disease / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D005069:Evaluation Studies as Topic; D005243:Feces / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D010586:Phagocytes / Q000502:physiology*; D011877:Radionuclide Imaging; D013667:Technetium / Q000378:metabolism
chemical_list: D013667:Technetium